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Intravenous injection of neural progenitor cells
improved depression-like behavior after cerebral
ischemia
Y Moriyama, N Takagi and K Tanonaka
Poststroke depression (PSD) occurs in approximately one-third of stroke survivors and is one of the serious sequelae of stroke.
The onset of PSD causes delayed functional recovery by rehabilitation and also increases cognitive impairment. However,
appropriate strategies for the therapy against ischemia-induced depression-like behaviors still remain to be developed. Such
behaviors have been associated with a reduced level of brain-derived neurotrophic factor (BDNF). In addition, accumulating
evidence indicates the ability of stem cells to improve cerebral ischemia-induced brain injuries. However, it remains to be
clariﬁed astothe effectofneuralprogenitorcells(NPCs)on PSD andthe association betweenBDNF levelandPSD. Using NPCs,
we investigated the effect of intravenous injection of NPCs on PSD. We showed that injection of NPCs improved ischemia-
induced depression-like behaviors in the forced-swimming test and sucrose preference test without having any effect on the
viable area between vehicle- and NPC-injected ischemic rats. The injection of NPCs prevented the decrease in the level of BDNF
in the ipsilateral hemisphere. The levels of phosphorylated CREB, ERK and Akt, which have been implicated in events
downstream of BDNF signaling, were also decreased after cerebral ischemia. NPC injection inhibited these decreases in the
phosphorylation of CREB and ERK, but not that of Akt. Our ﬁndings provide evidence that injection of NPCs may have
therapeutic potential for the improvement of depression-like behaviors after cerebral ischemia and that these effects might be
associated with restoring BDNF-ERK-CREB signaling.
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Introduction
Stroke is the most common severe neurological disorder and
a major cause of mortality among adults, followed by cancer
and myocardial infarction.
1 In addition, stroke survivors suffer
severe aftereffects, including motor dysfunction, cognitive
impairmentandmooddisorder.Poststrokedepression(PSD),
occurring in approximately one-third of stroke survivors,
is a serious sequelae of stroke.
2 The onset of PSD causes
delayed recovery from the cerebral infarction, adversely
affects motor function recovery by rehabilitation,
3 and
increases cognitive impairment
4 and the risk of suicide.
5
Furthermore, it is likely that stroke patients may have relevant
mood disorders despite good functional outcome.
6 However,
evidence for effective treatments for PSD has not been well
developed.
Accumulatingevidencehassuggestedthatimpairedneuro-
genesis is linked to affective disorders, including depres-
sion.
7,8 Furthermore, several lines of evidence indicate the
ability of antidepressants to elicit neurogenesis, thus suggest-
ing the importance of the latter in mediating the therapeutic
effect of antidepressants.
7,9,10 Proliferation of neural progeni-
tor cells (NPCs) is enhanced by cerebral ischemia.
11–13 It was
demonstrated that newly generated cells migrate to the site
ofinjuryinthebrain,
14,15andthatthesemigratedcellsexpress
markers of mature neurons.
14,16 The majority of newly gene-
rated endogenous neurons fail to survive, although some
of them persist for up to 5 weeks after brain ischemia.
14,16
Therefore, it has been suggested that transplantation of cells
would be onepotential strategyfor the treatment ofstroke
17,18
and other progressive neurodegenerative diseases.
It was earlier reported that the transplantation of stem or
progenitor cells induces improvement of motor and cognitive
functions and neurological deﬁcits. Indeed, we demonstrated
previously that the injection of NPCsimproves spatiallearning
andmemorydysfunction,whichwereevaluatedbyperforming
a water maze task, after cerebral ischemia.
19,20 However,
it remains to be clariﬁed whether transplantation of NPCs
can improve PSD.
Several studies have suggested that brain-derived neuro-
trophic factor (BDNF) is associated with the pathophysiology
of depression.
21,22 In this regard, chronic stress reduces the
expression of BDNF in the hippocampus,
23 whereas chronic
administration of an antidepressant increases BDNF expres-
sion there.
24–26 Moreover, infusion of BDNF into the hippo-
campus exerts an antidepressant effect as assessed by
the learned helplessness and forced-swimming test (FST)
paradigms.
22 Despite accumulating data suggesting an
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www.nature.com/tpassociation between decreased brain BDNF levels and
depression, there are no data regarding the effect of trans-
plantation of NPCs on cerebral ischemia-induced depression
or on the level of BDNF in the brain.
The aims of this study were to determine whether intra-
venous injection of NPCs could improve ischemia-induced
depression-like behaviors. We furthermore sought to deter-
mine the molecular changes, including those in BDNF levels
and ERK/CREB signaling, underlying the pathophysiology
of cerebral ischemia-induced depression-like behaviors. As
NPCs were prepared from green-ﬂuorescent protein (GFP)
transgenic rats by using the neurosphere method, cells
derived from these NPCs were also characterized in situ after
the intravenous injection of them into ischemic rats.
Materials and methods
NPC cultures. NPCs were prepared from gestational Day
14 fetal GFP transgenic rats as described previously.
19,27,28
The GFP transgenic rats (Wistar-TgN (CAG-GFP) 184ys)
used in this study were provided by National Bio Resource
Project for the Rat in Japan (Kyoto, Japan). The origin
and characteristics of the transgenic rats were described
previously.
29 Cells were seeded at a density of 50000 cells
per cm
2 into non-treated ﬂasks (Nalge Nunc International,
New York, NY, USA) containing N-2 plus medium supple-
mented with 20ngml
 1 epidermal growth factor and
20ngml
 1 basic ﬁbroblast growth factor (growth medium).
NPCs were grown in culture as free-ﬂoating neurosphere,
and 80% of the medium was exchanged for new growth
medium on Day 4. For the experiments, neurospheres
cultured for 6 days in vitro were used. The protocol was
approved by the Committee of Animal Care and Welfare of
Tokyo University of Pharmacy and Life Sciences.
For immunostaining of ﬂoating cultured neurospheres, they
wereincubatedonpoly-L-lysine(Sigma-Aldrich,StLouis,MO,
USA)-coated slides for 1h at 251C. The attached neuro-
spheres were ﬁxed for 30min with 4% paraformaldehyde.
The primary antibodies used for neurospheres were mouse
monoclonal anti-nestin (BD Bioscience, Franklin, NJ, USA)
and rabbit polyclonal anti-musashi-1 (Chemicon, Temecula,
CA, USA). Omission of primary antibodies served as negative
controls. No immunostaining was detected in the group of
negative controls.
For differentiation, neurospheres were cultured for 6 days
in vitro, followed by replacement of the medium with
Dulbecco’s modiﬁed Eagle’s medium/F12 medium without
epidermal growth factor and basic ﬁbroblast growth factor on
Day 7. The neurospheres were then cultured for 7 additional
days. For immunostaining of differentiated NPCs, the follow-
ing primary antibodies were used: mouse monoclonal anti-
MAP2 (Sigma-Aldrich), detecting neurons; rabbit polyclonal
anti-glial ﬁbrillary acidic protein (GFAP) (DAKO, Carpinteria,
CA, USA), labeling astrocytes; and mouse monoclonal
anti-mouse monoclonal anti-oligodendrocytes (clone RIP)
(Chemicon), marking oligodendrocytes.
Thesecondaryantibodiesusedwereasfollows:ﬂuorescein
isothiocyanate-conjugated donkey anti-mouse immuno-
globulin G (IgG) (Jackson Immunoresearch, West Grove,
PA, USA) or Cy3-conjugated donkey anti-rabbit IgG
(Jackson Immunoresearch). Fluorescence was detected
using Olympus ﬂuorescence microscopy (BX-52; Olympus,
Tokyo, Japan) or with a KEYENCE BZ-8000 (KEYENCE,
Osaka, Japan). Omission of primary antibodies served as
negative controls, which showed no immunostaining.
Model of microsphere-induced cerebral embolism in
rat. Male wistar rats weighing 220–250g (Charles River
Japan Inc., Atsugi, Japan) were used. The rats were main-
tained at 23±11C in a room with a constant humidity
of 55±5% and a light cycle of 12-h light:12-h darkness.
The rats had free access to food and water according to
the National Institute of Health Guide for the Care and Use
of Laboratory Animals and the Guidance for Experimental
Animal Care issued by the Prime Minister’s Ofﬁce of Japan.
The study was approved by the Committee of Animal Care
and Welfare of Tokyo University of Pharmacy and Life
Sciences.
Microsphere-induced cerebral embolism was performed by
the method described previously.
19,30 After rats had been
anesthetized by an intraperitoneal injection of 40mgkg
 1
sodium pentobarbital, the right external carotid and pterygo-
palatine arteries were temporarily occluded with strings.
Immediately, a needle connected to a polyethylene catheter
(3 French Atom, Tokyo, Japan) was inserted into the right
common carotid artery, and then 700 microspheres (47.5±
0.5mm in diameter; Perkin-Elmer Life Sciences, Waltham,
MA, USA), suspended in 20% dextran solution, were injected
into the right internal carotid artery through the cannula.
After the injection, the needle was removed, and the puncture
wound was repaired with surgical glue. The rats that under-
went a sham operation received the same volume of vehicle
without microspheres.
Neurological deﬁcits. Neurological deﬁcits of microsphere-
embolized rats were scored on the basis of paucity of
movement, truncal curvature and forced circling during loco-
motion according to the criteria described previously.
31,32
The score of each neurological deﬁcit was rated from 3 to 0
(3, very severe; 2, severe; 1, moderate; 0, little or none). The
rats with a total score of 7–9 points on Day 1 after cerebral
embolism were used in this study.
Administration of NPCs. Neurospheres were dispersed in
the enzyme solution and resuspended in N-2 plus medium
to a ﬁnal concentration of 1.0 10
6 cells/100ml. The cell
suspension (100ml) was administered via the right femoral
vein on Day 7 after the cerebral embolism. Vehicle was
injected in a similar manner as the NPCs.
Behavioral test. A series of behavioral tests, including
motor, sensory, reﬂex and balance tests, was performed on
Days 1, 7, 14, 21 and 28 after cerebral embolism according
to the modiﬁed Neurological Severity Scores (mNSS)
33 by a
researcher who was blinded to the experimental groups. The
score of mNSS was rated from 0 to 18 (normal score, 0;
maximal deﬁcit score, 18). In this scoring system, 1 score
point is awarded for the inability to perform the test or for the
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severe is the injury.
Open-ﬁeld test. The open-ﬁeld test was performed on Day
28 after cerebral embolism according to a modiﬁed version of
the test described previously.
34 The open-ﬁeld apparatus
consisted of a square arena with black walls (90 90 
45cm
3). The ﬂoor of the apparatus was divided equally
into 25 squares marked by white lines. The rats were placed
individually into the center of the arena and allowed to
explore for 15min. The locomotor activity was measured by
counting the number of crossings (squares crossed with all
paws). Before each session, the ﬂoor was cleaned.
Sucrose preference test. A battery of the sucrose
preference test (SPT) was performed before surgery and on
Days 7, 14, 21 and 28 after cerebral embolism. Rats were given
access for 12h (1900 hours until 0700 hours) to two drinking
spouts (water and 1% sucrose solution) positioned side by
side (1900 hours until 0700 hours) after water deprivation
for 6h. Bottle positions were switched at 6h after the start
of the test. At the end of test, the consumption was noted.
Sucrose preference was calculated according to the following
ratio: sucrose preference¼(sucrose consumption (ml)/(water
consumption (ml)þsucrose consumption (ml)) 100.
Forced-swimming test. The FST was performed at Day 28
after surgery for the induction of cerebral embolism or on the
sham animals. Rats were placed in a dark transparent acrylic
cylinder (60cm in height, 20cm in diameter) ﬁlled to 30cm
with water (25±11C) and kept there for 15min. Then, the
animals were removed from the water, dried with towels and
placed in their cage. The 5-min test session was conducted
24h later, and the duration of immobility of the rats was
recorded. Immobility was deﬁned as the lack of motion of the
whole body, except for small movements necessary to keep
the rat’s head above the water.
Histological assessments. On Day 28 after surgery,
cerebral embolism or sham rats were perfused via the heart
with 4% paraformaldehyde in 0.1M phosphate buffer. Their
brains were quickly removed and immersed in 30% sucrose in
0.1 M phosphate buffer. The brains were then cut into 5-mm-
thick coronal slabs, which were subsequently embedded in
Neg50 (Richard-Allan Scientiﬁc, Kalamazoo, MI, USA) and cut
into 10-mm sections by using a cryostat. For determination of
the viable area, coronal sections were stained with hema-
toxylin and eosin. The viable area in the ipsilateral hemisphere
was measured as a percentage of that of the contralateral
hemisphere by using NIH Image ver. 1.63.
For immunostaining, sections were incubated overnight
with the desired primary antibody at 41C, and then with the
corresponding secondary antibody for 1h. In the case of
double immunoﬂuorescence staining, after a wash, the same
sections were incubated overnight with another primary
antibody at 41C. Subsequently, they were incubated with
the corresponding secondary antibody for 1h. Omission of
primary antibodies served as a negative control. No immuno-
staining was detected in this group.
The followingprimary antibodies wereused:ratmonoclonal
anti-GFP (Nacalai Tesque, Kyoto,Japan),mousemonoclonal
anti-NeuN (Chemicon), rabbit polyclonal anti-GFAP (DAKO),
mouse monoclonal anti-RIP (Chemicon) and rabbit polyclonal
anti-musashi-1 (Chemicon) antibodies. The secondary anti-
bodies used were as follows: ﬂuorescein isothiocyanate-
conjugated donkey anti-rat IgG (Jackson Immunoresearch),
Cy3-conjugated goat anti-mouse IgG (Amersham, Buckin-
ghamshire, UK) and Cy3-conjugated donkey anti-rabbit IgG
(Jackson Immunoresearch). Fluorescence was detected by
usingOlympusﬂuorescencemicroscopy(BX-52;Olympus)or
with a KEYENCE BZ-8000 (KEYENCE).
Immunoblotting. On Day 28 after surgery, cerebral embo-
lism or sham rats were killed by decapitation. The whole
ipsilateral hemisphere was homogenized in ice-cold buffer
containing 320mM sucrose, 20mM b-glycerophosphate,
20mM sodium diphosphate, 0.2mM sodium orthovanadate,
0.1mM phenylmethyl sulfonyl ﬂuoride, 5mgml
 1 antipain,
5mgml
 1 aprotinin and 5mgml
 1 leupeptin at 41C. To deter-
mine the level of BDNF proteins, the whole ipsilateral
hemisphere was homogenized in ice-cold buffer containing
10% sucrose, 1mM EDTA, phosphatase inhibitor cocktail
(Roche) and protease inhibitor cocktail (Roche, Mannheim,
Germany) in 20mM Tris-HCl (pH 7.4), and then centrifuged at
12000g for 12min at 41C; and ﬁnally the supernatant was
collected. Protein concentration was determined by the
method of Lowry.
35 Western blotting was performed accor-
ding to standard protocols. The following primary antibodies
were used: rabbit polyclonal antibody against BDNF (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA), phospho-
CREB (Cell Signaling Technology Inc., Danvers, MA, USA),
CREB (Cell Signaling Technology), phospho-ERK1/2 (Cell
Signaling Technology), ERK1/2 (Cell Signaling Technology),
phospho-Akt (Cell Signaling Technology), Akt (Cell Signaling
Technology) and TrkB (BD Biosciences). Subsequently, the
membrane was washed and incubated with secondary
antibody. Bound antibody was detected by use of the
enhanced chemiluminescence method (Amersham). Quanti-
ﬁcation was carried out by performing computerized densito-
metry with an image analyzer (ATTO Co., Tokyo, Japan). To
minimize between blot variability, we applied an aliquot of
pooled ‘control’ homogenates, which was obtained from naı ¨ve
control rats, to one lane of every gel and calculated the
immunoblotting of samples relative to this standard.
Statistical analysis. The results were expressed as the
means±standard error of the mean (s.e.m.). Differences
between two groups were evaluated statistically by the
unpaired Student’s t-test. Statistical comparison among
multiple groups was evaluated by analysis of variance,
followed by Scheffe’s test as a post hoc test or repeated
measures analysis of variance. P-values of less than 0.05
were considered signiﬁcant.
Results
Isolation of NPCs. Figure 1 shows that cells in the neuro-
spheres expressed the neural progenitor markers nestin
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in vitro. After triggering in vitro differentiation by withdrawal
of the growth factors, we conﬁrmed the tripotent nature of
the NPCs by their ability to generate differentiated cells
expressing neuronal (MAP2; Figure 1e), astrocytic (GFAP;
Figure 1f) and oligodendrocytic (RIP; Figure 1g) markers.
Effect of injection of NPCs on body weight and neuro-
logical deﬁcits. The time courses of the change in body
weight of the vehicle- and NPC-injected ischemic rats are
shown in Figure 2a. The body weight of both groups of
ischemic rats transiently decreased after the surgery, and
there was no signiﬁcant difference in body weight between
the two groups (F(1, 32)¼1.72, P¼0.20).
The time courses of the change in neurological deﬁcits of
vehicle-treated and NPC-injected ischemic rats are shown in
Figure 2b. The neurological deﬁcits of ischemic rats gradually
decreased after surgery for microsphere embolism. No
signiﬁcant improvement in the NPC-injected ischemic rats
was seen when these rats were compared with the vehicle-
treated ones (F(1, 32)¼0.58, P¼0.45) (Figure 2b).
Effect of injection of NPCs on mNSS. We next examined
the time courses of the change in mNSS of the vehicle-
treated and NPC-injected ischemic rats (Figure 2c). The
score of the vehicle-injected ischemic rats was 13.1±0.2
points on Day 1, dropped to 9.5±0.2 points on Day 7 after
microsphere embolism and remained at roughly that value up
to Day 28. There were signiﬁcant differences in the mNSS by
group (F(1,32)¼161.24, Po0.0001) and by days (F(4,32)¼
913.29, Po0.0001). The group-by-day interaction was signi-
ﬁcant. There was a signiﬁcant improvement in the score of
NPC-injected ischemic rats when these rats were compared
with the vehicle-injected ones after microsphere embolism
(Figure 2c). Sham-operated rats did not reveal any neuro-
logical deﬁcits and had no mNSS throughout the examination
(data not shown).
Effect of injection of NPCs on the SPT. The time courses
of the change in sucrose preference of the vehicle- and
NPC-injected ischemic rats are shown in Figure 3a. The
percentage of the sucrose preference of vehicle-injected
ischemic rats was 71.8±2.9% on Day 7 after the embolism.
Then, this percentage remained at about the same value up
to Day 28 after the embolism (Figure 3a). The percentage for
the sucrose preference score of NPC-injected ischemic rats
was 67.3±2.7% on Day 7 and then it gradually increased
(Figure 3a). There was a signiﬁcant difference in the percen-
tage of the sucrose preference by group (F(1,32)¼36.54,
Po0.0001) and by days (F(4,32)¼67.04, Po0.0001). There
Figure 1 Characterization of neural progenitor cells and experimental protocol of this study. Triple staining was carried outwith 40,6-diamidino-2-phenylindole (DAPI), (a)
and for nestin (b) and musashi-1 (c) was merged (d), and indicated that cells in neurospheres, which were prepared from gestational Day 14 fetal rats, expressed the neural
progenitor cell markers nestin and musashi-1 on Day 6 when cultured in vitro. The cells in the neurospheres differentiated after the withdrawal of growth factors from the
medium into MAP2- (e), glial ﬁbrillary acidic protein (GFAP)- (f) and oligodendrocytes (clone RIP)-positive cells (g). Scale bars represent 50mm( a–d) and 10mm( e–g).
Experimental protocol in this studywas depicted(h). Abbreviations:mNSS,modiﬁedNeurological SeverityScores; SPT, sucrosepreferencetest; FST,forced-swimming test;
OFT, open-ﬁeld test; WB: western immunoblotting; and IHC, immunohistochemistry.
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preference of NPC-injected ischemic rats when these rats
were compared with the vehicle-injected ones. The sham-
operated rats did not reveal any reduction in the sucrose
preference throughout the examination (data not shown).
There was no signiﬁcant difference in total consumption
between vehicle- and NPC-injected ischemic rats throughout
the experiment (Figure 3b).
Figure 2 Time courses of changes in body weight, neurological deﬁcits and
modiﬁedNeurologicalSeverity Score (mNSS)-of vehicle-andneural progenitorcell
(NPC)-injected ischemic rats. The arrow indicates the time point when NPCs or
vehicle was injected. There was no signiﬁcant difference in body weight between
NPC- (open circles) and vehicle-treated (closed circles) groups (a). The score of
each neurological deﬁcit was rated from 3 to 0 (from very severe to little or none).
There was no signiﬁcant improvement in the NPC-injected ischemic (closed circles)
rats compared with the vehicle-injected ischemic (open circles) ones (b).
Determination of mNSS, which is based on a series of behavioral tests, including
motor, sensory, reﬂex and balance tests, was made. There was a signiﬁcant
reduction in the score of NPC-injected ischemic rats (open circles) when these rats
were compared with the vehicle-injected ones (closed circles) after the embolism
(c). All results are presented as the mean±s.e.m. (n¼17 rats per group).
#Statistically signiﬁcant difference from vehicle-injected ischemic rats (Po0.05).
Figure 3 Effect of injection of neural progenitor cells (NPCs) on sucrose
preference, immobility time in the forced-swimming test and locomotor activity. A
battery ofthesucrosepreferencetest was conductedbeforemicrosphereembolism
and on Days 7, 14, 21 and 28 after the embolism (a and b). Time courses of
changes in sucrose preference of vehicle- (closed circles) and NPC-injected (open
circles)ischemicratsareshown(a).ThearrowsindicatethetimepointwhenNPCor
vehicle was injected. There was signiﬁcant improvement in the percentage of the
sucrose preference of the NPC-injected ischemic rats when these rats were
compared with the vehicle-injected ischemic ones on Days 14, 21 and 28 after the
embolism.Therewasnosigniﬁcantdifferenceintotalconsumptionbetweenvehicle-
and NPC-injected ischemic rats throughout the experiment (b). All results in the
sucrose preference test are presented as the mean±s.e.m. (n¼17 rats per
group). The forced-swimming test was performed on Day 28 after the embolism (c).
#Statistically signiﬁcant difference from vehicle-injected ischemic rats (Po0.05).
There was a signiﬁcant increase in the immobility of the vehicle-injected ischemic
rats when these rats were compared with the sham-operated ones (c). The
immobility time was not increased in NPC-injected ischemic rats (c). The open-ﬁeld
test was performed on Day 28 after the embolism (d). The total locomotor activity
was not signiﬁcantly different among sham-operated, vehicle-injected and NPC-
injected ischemic rats (d). All results in the forced-swimming test and the open-ﬁeld
test are presented as the mean±s.e.m. (n¼14 rats per group). *Statistically
signiﬁcant difference from sham-operated rats (Po0.05).
#Statistically signiﬁcant
difference from vehicle-injected ischemic rats (Po0.05).
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the effect of injection of NPCs on depression-like behavior,
we next conducted the FST on Day 28 after microsphere
embolism. The immobility time in the FST for the sham-
operated rats and the vehicle- and NPC-injected ischemic
rats is shown in Figure 3c. There was a signiﬁcant difference
in the mobility time among the three groups (F(2,39)¼7.27,
Po0.01). The immobility time of vehicle-injected ischemic
rats was signiﬁcantly increased, and this increased time was
attenuated by the NPC injection (Figure 3c).
Effect of injection of NPCs on the open-ﬁeld test. We
further examined the effect of NPCs on the locomotor activity
of the sham-operated rats and the vehicle- and NPC-injected
ischemic ones on Day 28 after the microsphere embolism or
sham surgery. As shown in Figure 3d, there was no signiﬁcant
difference in the locomotor activity among these three groups.
Effect of injection of NPCs on the viable area and
phenotype of injected NPCs. We examined the effect of
injection of NPCs on the viable area of the ipsilateral
hemisphere of vehicle-treated (Figures 4a and d) and NPC-
injected (Figures 4b and e) ischemic rats on Day 28 after the
microsphere embolism. The marked degeneration seen in
the vehicle-injected ischemic rats was not attenuated by the
injected NPCs (Figures 4c and f). The NPCs, which were
identiﬁed as GFP-positive cells, were found in the peri-infarct
region at 21 days after the injection. Although the injected
NPCs (GFP-positive cells) were not positive for RIP (data not
shown) after in vivo cerebral ischemia, a few injected NPCs
expressed NeuN (Figure 4k) and GFAP (Figure 4l) in the
peri-infarct areas at 21 days after the injection of NPCs. Most
injected NPCs were still positive for musashi-1 around the
infarct areas (Figure 4m).
Effect of injection of NPCs on the levels of BDNF,
phosphorylated CREB and TrkB. We examined the
effect of the NPC injection on the level of BDNF protein
(Figure 5a) and phospho-CREB (Figure 5b) in the ipsilateral
hemisphere of sham-operated rats and vehicle- or
NPCs-injected ischemic rats on Day 28 after microsphere
embolism. There were signiﬁcant differences in the level
Figure 4 Histological analysis of the neural progenitor cell (NPC)-injected brain after the embolism. Effect of injection of NPCs on the viable areas after the embolism. On
Day 28 after microsphere embolism-induced cerebral ischemia (ME), coronal sections were stained with hematoxylin and eosin. Photographs of hematoxylin- and eosin-
stainedsectionsareshownforvehicle-injected(aandd)andNPC-injected(bande)ischemicrats.Viableareaswereestimatedbymeasuringhematoxylin-andeosin-stained
sections (c and f) that corresponded to coronal coordinates of bregma from 0.48 to  0.30mm (striatal region: a–c) and from  3.80 to  4.52mm (hippocampal region: d–f).
All results are presented as the mean percentage of the contralateral hemisphere±s.e.m. (n¼8–9 rats per group). There was no signiﬁcant attenuation of tissue
degeneration in the NPC-injected ischemic rats compared with that in the vehicle-injected ischemic rats in both regions (c and f). Green-ﬂuorescent protein (GFP)-positive
NPCswerefound in theperi-infarctareas (hand j)on Day 28 aftertheembolism(striatalregion:g andh; hippocampalregion: i andj). Theimages(white square)in ‘g’ and‘i’
are enlarged in ‘h’ and ‘j’, respectively. To determine the effect of injection of NPCs on the phenotype of injected cells, double immunostaining in the peri-infarct areas was
conductedon Day 28 after theembolism.Some GFP-positive injectedNPCs expressedmature neuronalmarker NeuN (k) and astrocyte markerGFAP (l). MostGFP-positive
NPCs expressed NPC marker musashi-1 (m). Scale bars represent 1mm (g and i), 50mm( h and j) and 10mm( k–m).
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Translational Psychiatryof BDNF and phospho-CREB proteins among the three
groups (BDNF: F(2,24)¼37.71, Po0.0001; phospho-CREB:
F(2,24)¼7.94, Po0.01). The level of BDNF proteins was
decreased after the embolism compared with that in the
sham-operated rats (Figure 5a). The injection of NPCs
signiﬁcantly lessened this decrease in BDNF level in the
ischemic rats (Figure 5a). Phosphorylation of CREB was also
decreased on Day 28, and the NPC injection inhibited this
decrease without causing any change in the level of CREB
(Figure 5b). Furthermore, there was a signiﬁcant difference
in the level of the BDNF receptor TrkB protein among the
three groups (F(2, 14)¼26.99, Po0.0001). The decreased
level of TrkB protein in the ipsilateral hemisphere of the
vehicle-injected ischemic rats was attenuated by the injection
of the NPCs (Figure 5c).
Effect of NPC injection on the level of phosphorylated
ERK and Akt. We next examined the effect of the NPC
injection on the phosphorylation of ERK and Akt, which are
located upstream of CREB. There were signiﬁcant
Figure 5 Effect of neural progenitor cell (NPC) injection on the levels of brain-derived neurotrophic factor (BDNF), phosphorylated CREB, TrkB, phosphorylated ERK and
phosphorylated AKT on Day 28 after the embolism.Samplesobtained from sham-operated (sham), vehicle-injected ischemic (vehicle)and NPC-injected (NPC) ischemic rats
(ME)weresolubilizedandseparatedby sodiumdodecylsulfate-polyacrylamidegelelectrophoresis (SDS-PAGE).Bandscorrespondingto BDNF(a),phospho-CREB (b),and
TrkB(c),phosphorylatedERK(d)andphosphorylatedAkt(e)werescanned,andscannedbandswerenormalizedbyactin(aandc),totalCREB(b),totalERK(d)ortotalAKT
(e)onthesameblot.Allresultsarepresentedasmeanpercentagesofnon-operatednaı ¨ve rats±s.e.m.(BDNFandphospho-CREB: n¼9ratsper group;TrkB:n¼5–6rats
per group; and phospho-ERK and -AKT: n¼6 rats per group). *Statistically signiﬁcant difference from sham-operated rats (Po0.05).
#Statistically signiﬁcant difference from
vehicle-injected ischemic rats (Po0.05).
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among the three groups (phospho-ERK: F(2,15)¼14.74,
Po0.001; phospho-Akt: F(2,15)¼7.32, Po0.01). The micro-
sphere embolism decreased the level of phospho-ERK on
Day 28 (Figure 5d), and this decrease in the phosphorylation
of ERK was attenuated by the injection of NPCs without
changing the total level of ERK (Figure 5d). Although the
level of phosphorylated Akt was signiﬁcantly decreased after
the embolism compared with that for the sham-operated rats,
no statistical difference was detected in Akt phosphory-
lation between vehicle- and NPC-injected ischemic rats
(Figure 5e).
Discussion
In this study, NPCs proliferated and formed neurospheres
that expressed NPC markers nestin and musashi-1. The cells
in the neurospheres differentiated by withdrawal of the growth
factors in the medium into neurons, astrocytes and oligo-
dendrocytes in vitro. These results indicate the ability of
NPCs isolated from fetal GFP transgenic rats to express the
properties of self-renewal and multipotency.
As a transient inﬂammatory response occurs around the
injured region during the acute stage, this time period is not
likely to be suitable for therapeutic transplantation of cells.
36
We have previously conﬁrmed that the level of an inﬂamma-
tory cytokine IL-6 was comparable to that of sham-operated
control rats and that the body weight of embolized rats was
transiently decreased and then returned to baseline on
Day 7 after surgery.
20,37 In addition, the infarction had almost
completely developed in the ipsilateral hemisphere on Day 7
after surgery. Therefore, we injected NPCs on Day 7 after
microsphere embolism in this study, to avoid inappropriate
environments for therapeutic NPC injection after cerebral
ischemia. We showed that there was no signiﬁcant difference
in the time course of the change in the neurological deﬁcits,
regardless of intravenous injection or not of NPCs. As
described previously, the neurological deﬁcits seen in micro-
sphere embolism-induced cerebral ischemia in rats can only
be useful as stroke-like symptoms to assess the severity of
ischemic models during the acute period after surgery.
19
Thus, these results imply that the effect of the NPCs on
mNSS, sucrose preference and the immobility time in the
FST evaluated in this study was not due to alterations of
neurological deﬁcits during the acute period after surgery.
In this study, there was a signiﬁcant group-by-day inter-
action in the mNSS. Therefore, it was suggested that the
intravenous injection of NPCs on Day 7 after the induction of
cerebral ischemia improved the results in a series of motor
sensory, reﬂex and balance tests for the mNSS, compared
with those for the vehicle-injected ischemic rats. This effect
of NPCs is consistent with the ﬁnding that intravenous
administration of bone marrow stromal cells after transient
focal cerebral ischemia reduces functional deﬁcits.
38,39
Accumulating evidence indicates that the recovery of neuro-
logical function after cerebral ischemia is mediated by the
production of some trophic factors, vascular remodeling and
axonal regeneration,
40,41 although it is still not clear why
the intravenous injection of NPCs was effective in reducing
the mNSS.
We performed the SPT and FST as measures of PSD-like
behavior. Inthis study,the sucrosepreferenceof theischemic
rats decreased at 7 days after surgery and this decrease was
sustained at least until Day 28. This result is consistent with
the decreased sucrose preference in middle cerebral artery
occlusion models with chronic mild stress.
42 As a decrease in
sucrose consumption indicates a state of anhedonia, a core
symptom of depression, which can be evaluated effectively
in rodents,
43 our results can be used to estimate a mood
disturbance of rats after microsphere embolism. We further-
more showed that the immobility time in the FST was
prolonged in the vehicle-treated ischemic rats. These results
suggest that microsphere embolism-induced cerebral ische-
mia affected behaviors associated with depression. On the
basis of these results, our present study is the ﬁrst to provide
evidence that the intravenous injection of NPCs can improve
PSD-like behaviors.
Intravenously injected NPCs homed into the ischemic
hemisphere, but not into the contralateral hemisphere, on
Day 28 after the embolism. This result raises the possibility
that the injected NPCs integrated into the damaged area and
might provide growth factors because most of these cells did
not undergo differentiation. It was earlier shown that systemi-
cally injected endothelial progenitor cells homed into the
ischemic regions as early as 24h after transient middle
cerebral artery occlusion.
44 In this study, some GFP-positive
NPCs became localized in the hippocampus and hypo-
thalamus, which were consistent with lesion sites after the
embolism. In addition, the administration of bone marrow
stromal cells to rats with middle cerebral artery occlusion
enhances axonal plasticity, which is highly and signiﬁcantly
correlated with progressive functional recovery enhanced by
these bone marrow stromal cells, whereas no signiﬁcant
differenceisfoundontheischemiclesionbetweencontroland
bone marrow stromal cell treatment group.
45 Interestingly, we
demonstrated that the intravenous injection of NPCs on Day 7
after the embolism improved PSD-like behaviors without
havinganyrestorativeeffectonthedamagedareasonDay28
after the embolism. Although some injected GFP-positive
NPCs expressed NeuN and GFAP, most of the injected NPCs
did not undergo differentiation in this study. These results
imply that injected NPCs may exert several types of cellular
responses in the peri-infarct areas. Therefore, these injected
NPCs were maintained in an undifferentiated condition
morphologically and might not only have functioned as cells
producing neurotrophic factors, but also have protected host
viable cells and/or achieve an exact reconnection of neural
networks. Although the primary mechanism was presently not
fully elucidated, the altered expression of trophic factors as
well as biochemical responses induced by NPCs may have
contributed to the antidepression-like effects of these cells
after the embolism.
Among neurotrophic factors, BDNF plays an important role
in cellular proliferation and differentiation and contributes to
the maintenance of neuronal function and structural integrity
of neurons in the CNS. In addition, depressed suicide patients
show a decreased level of BDNF in their brain tissue.
21
Therefore, we focused on a possible change in the level of
BDNF as underlying the PSD-like behaviors. Our results
suggest that a properly maintained level of BDNF achieved by
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PSD-like behaviors after cerebral ischemia. This effect might
be associated with the actions of chemical antidepressants in
the FST,
46 as well as in agreement with the effect of centrally
administered BDNF, including infusion of it into the mid-
brain,
47 hippocampus
22 and lateral ventricles.
48 Furthermore,
the anti-depressant-like effects of BDNF in the learned
helplessness paradigms are blocked by co-administration of
K252a, a broad-spectrum tyrosine kinase inhibitor.
22 The
effects of antidepressants on the behavioral responses are
inhibitedin conditional BDNF knockout mice and in transgenic
mice expressing a dominant-negative form of the BDNF
receptor TrkB.
49,50 These ﬁndings raise the possibility of an
important role of altered BDNF and/or BDNF receptor TrkB-
mediated signaling pathway in PSD-like behaviors.
It was earlier shown that administration of BDNF increases
the level of BDNF, and enhances the phosphorylation of ERK
aswell asthatof CREB, which have been implicated in events
downstream of BDNF-TrkB signaling.
51,52 BDNF-ERK-CREB
signaling has been implicated in antidepressant effects on
behavior.
51 In this regard, ERK is likely to be required for the
effects of BDNF infusion on depression-like behaviors
22 or for
the antidepressant action.
53 Furthermore, CREB expression
and its phosphorylation are sufﬁcient for an antidepressant-
like effect on behavioral responses.
54 These results suggest
that BDNF-TrkB-ERK-CREB signaling could be required for
an antidepressant response.
49,50 Also, the activation of Akt
via TrkB has been implicated in the BDNF-induced survival of
neurons.
55 Interestingly, we demonstrated that injection of
NPCs did not affect the decreased phosphorylation of Akt on
Day 28 after the embolism. Although we cannot fully rule out
the possibility that Akt phosphorylation might be increased at
some different time point by NPC injection and related to
antidepressantresponse,ourresults suggestthattheeffectof
NPCs on PSD-like behavioral responses may be associated
withimprovementintheBDNF-ERK-CREBsignalingpathway
in the viable areas.
In conclusion, the intravenous injection of NPCs improved
PSD-like behaviors without having any restorative effect on
the degeneration of the brain tissue. We demonstrated that
restoring the BDNF-ERK-CREB signaling pathway by NPCs
was paralleled with improvement of PSD-like behaviors.
Although future studies will be required to explore the mecha-
nisms concerning the source of increased BDNF, this study
provides evidence of the therapeutic potential of NPCs for
improvement of PSD-like behaviors after cerebral ischemia.
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgements. We thank Chisa Itokawa, Sachiko Tsuru, Kanae
Hashimura andShokoMizukamifortheircontributiontotheresearch.Thisresearch
was supported in part by the Promotion and Mutual Aid Corporation for Private
Schools of Japan.
1. Stroke—1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of
the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989; 20:
1407–1431.
2. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a
systematic review of observational studies. Stroke 2005; 36: 1330–1340.
3. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM.
Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry
1995; 166: 320–327.
4. Austin MP, Mitchell P, Goodwin GM. Cognitive deﬁcits in depression: possible implications
for functional neuropathology. Br J Psychiatry 2001; 178: 200–206.
5. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between
depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med
2000; 160: 1761–1768.
6. Schwab-Malek S, Vatankhah B, Bogdahn U, Horn M, Audebert HJ. Depressive symptoms
and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol 2010; 257:
1848–1854.
7. Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and
antidepressants. Biol Psychiatry 2006; 59: 1136–1143.
8. Thomas RM, Hotsenpiller G, Peterson DA. Acute psychosocial stress reduces cell survival
in adult hippocampal neurogenesis without altering proliferation. J Neurosci 2007; 27:
2734–2743.
9. Malberg JE, Schechter LE. Increasing hippocampal neurogenesis: a novel mechanism for
antidepressant drugs. Curr Pharm Des 2005; 11: 145–155.
10. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I et al. Neurogenesis-
dependent and -independent effects of ﬂuoxetine in an animal model of anxiety/
depression. Neuron 2009; 62: 479–493.
11. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP et al. Neurogenesis in dentate
subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat.
Proc Natl Acad Sci USA 2001; 98: 4710–4715.
12. Kawai T,Takagi N, Miyake-Takagi K, Okuyama N, Mochizuki N, Takeo S. Characterization
of BrdU-positive neurons induced by transient global ischemia in adult hippocampus.
J Cereb Blood Flow Metab 2004; 24: 548–555.
13. Zhang RL, Zhang ZG, Zhang L, Chopp M. Proliferation and differentiation of progenitor
cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia.
Neuroscience 2001; 105: 33–41.
14. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endo-
genous precursors in the adult brain after stroke. Nat Med 2002; 8: 963–970.
15. GoingsGE,SahniV,SzeleFG.Migrationpatternsofsubventricularzonecellsinadultmice
change after cerebral cortex injury. Brain Res 2004; 996: 213–226.
16. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM. Rat forebrain neurogenesis and
striatal neuron replacement after focal stroke. Ann Neurol 2002; 52: 802–813.
17. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells
for the treatment of ischemic stroke. J Neurol Sci 2008; 265: 73–77.
18. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S et al. Stem
cell therapy in stroke. Cell Mol Life Sci 2009; 66: 757–772.
19. Mochizuki N, Takagi N, Kurokawa K, Onozato C, Moriyama Y, Tanonaka K et al. Injection
of neural progenitor cells improved learning and memory dysfunction after cerebral
ischemia. Exp Neurol 2008; 211: 194–202.
20. Mochizuki N, Takagi N, Onozato C, Moriyama Y, Takeo S, Tanonaka K. Delayed injection
of neural progenitor cells improved spatial learning dysfunction after cerebral ischemia.
Biochem Biophys Res Commun 2008; 368: 151–156.
21. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene
expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in
postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804–815.
22. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic
factor produces antidepressant effects in behavioral models of depression. J Neurosci
2002; 22: 3251–3261.
23. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect
the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the
hippocampus. J Neurosci 1995; 15: 1768–1777.
24. Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin
Pharmacol 2007; 7: 18–21.
25. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders.
Biol Psychiatry 2006; 59: 1116–1127.
26. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal
neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
Behav Pharmacol 2007; 18: 391–418.
27. Chiasson BJ, Tropepe V, Morshead CM, van der Kooy D. Adult mammalian forebrain
ependymal and subependymal cells demonstrate proliferative potential, but only subepen-
dymal cells have neural stem cell characteristics. J Neurosci 1999; 19: 4462–4471.
28. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2
activates a latent neurogenic program in neural stem cells from diverse regions of the adult
CNS. J Neurosci 1999; 19: 8487–8497.
29. Hakamata Y, Tahara K, Uchida H, Sakuma Y, Nakamura M, Kume A et al. Green
ﬂuorescent protein-transgenic rat: a tool for organ transplantation research. Biochem
Biophys Res Commun 2001; 286: 779–785.
30. Miyake K, Takeo S, Kaijihara H. Sustained decrease in brain regional blood ﬂow after
microsphere embolism in rats. Stroke 1993; 24: 415–420.
31. Furlow Jr TW, Bass NH. Arachidonate-induced cerebrovascular occlusion in the rat. The
role of platelets and aspirin in stroke. Neurology 1976; 26: 297–304.
NPCs improve brain ischemia-induced depression
Y Moriyama et al
9
Translational Psychiatry32. McGraw CP. Experimental cerebral infarction effects of pentobarbital in Mongolian gerbils.
Arch Neurol 1977; 34: 334–336.
33. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. An experimental model of
closed head injury in mice: pathophysiology, histopathology, and cognitive deﬁcits. J
Neurotrauma 1996; 13: 557–568.
34. Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine
monophosphate response element binding protein overexpression in the basolateral
amygdala on behavioral models of depression and anxiety. Biol Psychiatry 2004; 56:
151–160.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin
phenol reagent. J Biol Chem 1951; 193: 265–275.
36. Okano H, Kaneko S, Okada S, Iwanami A, Nakamura M, Toyama Y. Regeneration-based
therapies for spinal cord injuries. Neurochem Int 2007; 51: 68–73.
37. Mochizuki N, Moriyama Y, Takagi N, Takeo S, Tanonaka K. Intravenous injection of neural
progenitor cells improves cerebral ischemia-induced learning dysfunction. Biol Pharm Bull
2011; 34: 260–265.
38. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M et al. Therapeutic beneﬁt of intravenous
administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;
32: 1005–1011.
39. Zacharek A, Shehadah A, Chen J, Cui X, Roberts C, Lu M et al. Comparison of bone
marrowstromalcellsderivedfromstrokeandnormalratsforstroketreatment.Stroke2010;
41: 524–530.
40. Zacharek A, Shehadah A, Chen J, Cui X, Roberts C, Lu M et al. Comparison of bone
marrowstromalcellsderivedfromstrokeandnormalratsforstroketreatment.Stroke2010;
41: 524–530.
41. Zhang J, Li Y, Chen J, Yang M, Katakowski M, Lu M et al. Expression of insulin-like growth
factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res
2004; 1030: 19–27.
42. GuoYJ,ZhangZJ,WangSH,SuiYX,SunY.Notch1signaling,hippocampalneurogenesis
and behavioral responses to chronic unpredicted mild stress in adult ischemic rats.
Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 688–694.
43. Brenes Saenz JC, Villagra OR, Fornaguera Trias J. Factor analysis of forced swimming
test, sucrose preference test and open ﬁeld test on enriched, social and isolated reared
rats. Behav Brain Res 2006; 169: 57–65.
44. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J et al. Endothelial progenitor cell
transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 67:
488–497.
45. Liu Z, Li Y, Zhang ZG, Cui X, Cui Y, Lu M et al. Bone marrow stromal cells enhance
inter- and intracorticalaxonal connectionsafter ischemicstroke in adult rats.J Cereb Blood
Flow Metab 2010; 30: 1288–1295.
46. Cryan JF, Page ME, Lucki I. Differential behavioral effects of the antidepressants
reboxetine, ﬂuoxetine, and moclobemide in a modiﬁed forced swim test following chronic
treatment. Psychopharmacology (Berl) 2005; 182: 335–344.
47. SiuciakJA,LewisDR,WiegandSJ,LindsayRM.Antidepressant-likeeffectofbrain-derived
neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131–137.
48. Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to
long-lasting antidepressant-like effects. Brain Res 2005; 1037: 204–208.
49. Monteggia LM, BarrotM, Powell CM, Berton O, Galanis V, Gemelli T et al. Essentialrole of
brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA
2004; 101: 10827–10832.
50. Sairanen M, Lucas G, Ernfors P, Castren M, Castren E. Brain-derived neurotrophic
factor and antidepressant drugs have different but coordinated effects on neuronal
turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005; 25:
1089–1094.
51. Schmidt HD, Banasr M, Duman RS. Future antidepressant targets: neurotrophic factors
and related signaling cascades. Drug Discov Today Ther Strateg 2008; 5: 151–156.
52. Carlezon Jr WA, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005;
28: 436–445.
53. Gourley SL, Wu FJ, Kiraly DD, Ploski JE, Kedves AT, Duman RS et al. Regionally speciﬁc
regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression.
Biol Psychiatry 2008; 63: 353–359.
54. Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, Malberg J et al. Localization of
phosphorylated cAMP response element-binding protein in immature neurons of adult
hippocampus. J Neurosci 2002; 22: 9868–9876.
55. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond Ser B
2006; 361: 1545–1564.
Translational Psychiatry is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-
No Derivative Works 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
NPCs improve brain ischemia-induced depression
Y Moriyama et al
10
Translational Psychiatry